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Abstract: The PHARMINE (“Pharmacy Education in Europe”) project studied the organisation of
pharmacy practice and education in the member states of the European Union (EU). The work was
carried out using an electronic survey sent to chosen pharmacy representatives. The surveys of the
individual member states are now being published as reference documents. This paper presents the
results of the PHARMINE survey on pharmacy practice and education in Latvia. In the light of this,
we examine the harmonisation of practice and education in Latvia with EU norms.
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1. Introduction
The PHARMINE (“Pharmacy Education in Europe”) consortium surveyed the state of pharmacy
practice and education in the member states of the European Union (EU), including Latvia, between
2008 and 2011, with an update in 2017. The methodology used in the PHARMINE study and the
principal results obtained have already been published [1].
In the first part of the study, PHARMINE gathered information on general, community practice,
on specialised hospital and industrial practice, and on education and traineeship for pharmacists.
PHARMINE also dealt with other personnel working in pharmacies such as pharmacists’ assistants:
their education, training and responsibilities.
PHARMINE went on to study the legal and administrative context of pharmacy practice and
education. In the EU—in contrast to other parts of the world—pharmacy practice and education
fall under two jurisdictions: national and European. The latter is confederal both in structure
and decision-making. Freedoms of movement, of residence, and of exercise of profession are the
cornerstones of the EU. Thus, there is a system of automatic recognition of professional qualifications for
seven sectoral professions (nurses, midwives, doctors, dentists, pharmacists, architects and veterinary
surgeons). To work in another EU member state, professionals apply to the relevant authority of that
country, providing proof of the qualifications (for harmonised EU practice) obtained in their home state.
For sectoral professions, the European Commission of the EU issues directives; the latter are ordinances,
laying down the broad imperatives, on the practice and education of the given profession [2]. An EU
directive requires member states to achieve a particular result—in this case harmonisation of practice
and education—without dictating the means of achieving that result. Directives leave the different
member states with leeway as to the exact rules to be adopted. Member states may organise systems
that are more or less harmonised with the EU paradigm.
In parallel to the above pan-national system, member states may introduce specific national
legislation relating to specialised practice, and to ownership and management of pharmacies,
for example.
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This paper looks at how EU legislation impacts on pharmacy practice and education in Latvia.
Pharmacy education and training in Europe is also influenced by the Bologna agreement on
the harmonization of European degree courses, and student and staff exchange [3]. The Bologna
agreement, signed by the education ministers of the governments of the European Higher Education
Area (48 members including the 28 EU member states), proposes recommendations that are not legally
binding. They include a harmonised structure for all university degrees (including pharmacy) with a
bachelor (3 years) followed by a master’s (2 years) degree. Here, the Bologna agreement is in opposition
to the EU directive. The latter requires a five-year, “tunnel” degree structure for pharmacy, i.e., a degree
course that offers no possibility for intermediate entry or exit after (successful) accomplishment of
a three-year bachelor period. The idea behind the Bologna recommendation on degree structure is
to improve student mobility. Mobility is also behind other Bologna recommendations such as the
development of tools to promote student exchange programmes like the European Credit Transfer and
Accumulation System (ECTS). This provides credits to students for defined learning outcomes and
their associated workload. ECTS are coupled with the Diploma Supplement that describes the nature,
level, context, content and status of the studies that were successfully completed by a student at a
given university. This system allows students to validate studies carried out at their host university by
their home university.
This paper looks at how the Bologna process has developed in Latvian universities. It is
particularly interesting to examine how this affects education and practice in a country, Latvia, that has
recently joined the EU (2004).
In order to place pharmacy practice within the general health situation in Latvia compared to the
EU, it can be noted that life expectancy at birth (Table 1) in Latvia is lower than (males) or equal to
(females) the EU average of 79.4 years. Healthy life expectancy (EU average 70.2 years) is much lower
in males and slightly lower in females. Furthermore, expenditure on health is much lower than the EU
average ($3611 per capita).
Table 1. Health statistics for Latvia [4,5].
Total Population 1,970,000
Life expectancy at birth m/f (years) 70/79
Healthy life expectancy at birth m/f (years) 58/68
Total expenditure on health per capita $940
2. Design
Information was obtained from two pharmacy departments in Latvia: the University of Latvia
(UL, Ruta Muceniece and Una Riekstin, a) and Riga Stradins University (RSU, Baiba Maurina and Vija
Enina), which replied to questions on:
• pharmacy;
# practice (community, hospital and industrial);
# legislation;
# education and training;
• harmonisation with the EU sectoral directive on pharmacy;
• harmonisation with the Bologna recommendations (organisation of the degree course with the
existence or not of a bachelor/master’s structure, implementation of ECTS and the Erasmus
programme on student and staff exchange [6].
An electronic survey methodology was used and data was collected in 2010 and revised in 2017.
We attempted at all times to collect objective data.
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The information is presented in the form of tables in order to facilitate legibility. This type of
presentation was developed in association with the journal’s editorial board and has been described in
detail in a previous publication [7]. This format will ease the comparison of different EU countries
by students and staff envisaging exchange programmes, and by researchers in pharmacy education
and practice.
3. Evaluation and Assessment
3.1. Organisation of the Activities of Pharmacists, Professional Bodies
Table 2 provides details of the numbers and activities of community pharmacists and pharmacies
in Latvia. Items are expounded in the “comments” column.
Table 2. Numbers and activities of Latvian community pharmacists and pharmacies [8–17].
Item Numbers Comments
Pharmacists 2111
Data from October 2017.
1,970,000 inhabitants/2111 comm. pharmacists = 933
inhabitants/pharmacist




The competencies of community pharmacists are:
a. supplying prescription medicines;
b. managing medicines for some ailments;
c. giving advice on medicines;
d. screening services (blood cholesterol, glucose, pressure, etc.).





Currently ownership is not limited to pharmacists.
According to the Latvian Pharmacy Law [12] a pharmacy may be
established in the form of a:
• pharmacist’s practice;
• joint practice (a civil law company);
• capitalised company.
When delivering pharmaceutical care in a pharmacy owned by a local
government or a person who is not a pharmacist, the respective person
shall enter into a contract with a certified pharmacist.
An in-patient medical treatment institution or a daytime hospital may
open a closed type of pharmacy.
A pharmacy in the form of a capital company may operate if at least
one of the following conditions has been complied with:
• no less than 50% of the shares in the capital company are owned
by a pharmacist;
• no less than one half of the members of the management board of






1 pharmacy per 2000 inhabitants; at least 500 m between each pharmacy
that has an extemporaneous dispensing and/or a 24-h duty
pharmacy service.
An affiliate cannot be less than 5 km from the main pharmacy [17].






Yes It is possible to buy food supplements, hygiene products, and medicaldevices in specialised shops.
No All medicines, bandages, specific plasters (silicon etc.) are availableonly in pharmacies.
Yes
There is one e-pharmacy in Latvia. http://www.webaptieka.lv/en/
(opened November 2017). It is possible for customers from other EU
countries to order non-prescription medicines and other products from
this e-pharmacy.
Pharmacy 2018, 6, 9 4 of 18
The data in Table 2 shows that compared to the EU linear regression estimation (for definition
and calculation see Reference [1]), the ratio of the actual number of community pharmacists in Latvia
(/population) compared to the linear regression estimation for Latvia = 1.09. Thus, the number
of pharmacists per population is similar to the EU norm. The same comparison for community
pharmacies produces a ratio of 1.24, above the EU norm. The use of the linear regression estimation
is based on the following. Results here and elsewhere are not normal in distribution but highly
skewed [1]. Skewness was due to the uneven distribution of population in the EU. A small proportion
of the population of the EU lives in 18 smaller countries: Austria, Belgium, Bulgaria, Croatia, the
Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Ireland, Latvia, Lithuania, Malta,
Portugal, Slovakia, Slovenia and Sweden, and the larger proportion in 8 larger countries: France,
Germany, Italy, the Netherlands, Poland, Romania, Spain and the United Kingdom. In countries
with a larger population, the numbers of pharmacists, etc. are greater. As the number of countries
with a small population is large this leads to skewness in the distribution. Therefore, we used an EU
linear regression estimation to compare the data for a given country with the EU average. This was
calculated taking the numbers of pharmacists, etc. as the dependent variable with the population
as the independent variable. The reported number for the country was expressed as a ratio of the
number estimated from this linear regression. As the comparison is now with transformed (corrected
for population) data that are originally skewed, parametric tests such as the t-test with p values are
not given.
The activities and occupations of pharmacists in Latvia are similar to those of community
pharmacists in other EU member states [1]; a specificity of Latvia is the existence of internet
pharmacy practice.
Table 3 provides details of the numbers and activities of persons other than pharmacists working
in pharmacies in Latvia.
Pharmacists’ assistants work under the supervision of the pharmacist. The legal definition of
the profession states: “A pharmacist’s assistant is a health care provider, a specialist who works
in pharmacies under the supervision of a pharmacist, and independently may sell health care or
body care products, prepares drugs for individual doctor prescriptions or medical institution written
requests (extemporal drugs). A pharmacist’s assistant works in wholesale markets and medicines
manufacturing plants and carries out duties according to the specifics of the work” [12]. The training
and functions of pharmacists’ assistants are harmonised with those in other EU member states [1].
Table 3. Numbers and activities of other personnel working in pharmacies in Latvia.
Item Numbers Comments
Are persons other than
pharmacists involved in
community practice?
Yes Pharmacists’ assistants with a college education.
Their numbers 1601 (2017)
This is a regulated profession with a diploma based on the European
Council Directive 92/51/EEC [18] on a second general system for the
recognition of professional education and training.
Pharmacy students, medical students and nurses who have not
completed their higher-education institution (HEI) course, can be
employed as technicians, i.e., support staff at a pharmacy. Such




Pharmacists’ assistants are trained at Riga 1st medical college (RMC)
and (since 2016) at the Red Cross Medical College (RCMC) where the
first 28 students matriculated in 2016. RCMC is an institution under the
supervision of RSU.
The programme lasts 2.5 years.
All programs are recognized by the Latvian Accreditation Centre
(Higher Education Quality Evaluation Centre (HEQEC)) and evaluated
by national and foreign experts [19].











GENERIC 760 (including traineeship in a pharmacy)
ELECTIVE 200 h
(For abbreviations see Reference [1]).








GENERIC 728 (including traineeship)
ELECTIVE 64 h
(For abbreviations see Reference [1]).
Competences and roles
• Extemporaneous drug preparation.
• Dispensing of non-prescription medicines under the guidance of
a pharmacist.
• Dispensing of hygienic and cosmetic products.
Turning to specialisation in pharmacy practice, Table 4 provides details of the numbers and
activities of hospital pharmacists in Latvia.





There are approximately 31 hospital pharmacies in Latvia.
Pharmacists working in hospitals have the same status as those working in
community pharmacies. In general, hospital pharmacists do not have a
specialised education but are simply pharmacists who work at hospital
pharmacies. Thus, their title is defined by their place of work. Clinical
pharmacists are defined by their education and function. Only 3 clinical
pharmacists are at present working in hospital pharmacies. They receive a
special education and are graduates of the clinical pharmacy master‘s




Pharmacists working at hospital pharmacies and those working at
community pharmacies are registered in one single register. There are
approximately 2111 registered pharmacists, of whom 83 pharmacists (and
34 pharmacists’ assistants) work in hospital pharmacies.
There is a specific section for hospital pharmacists within the Latvian
Pharmacists’ Society, and approximately 117 persons (83 pharmacists and
34 pharmacists’ assistants) are members of this section. The Latvian





• Purchasing of drugs and medical material.
• Unit-dose drug distribution.
• Production of patient-specific medicines (e.g., cytotoxic preparations).
The number of pharmacists working in hospitals is similar to the EU average. The ratio of the
actual number compared to the linear regression estimation is 1.23, (for definition and calculation see
Reference [1]). The ratio for hospital pharmacies compared to the EU average is 0.82.
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Table 5 provides details of the numbers and activities of industrial pharmacists and pharmacists
in other sectors, in Latvia.
Table 5. Numbers and activities of industrial pharmacists and pharmacists in other sectors.
Item Numbers Comments





Approximately 100 representative offices of foreign drug manufacturers were
registered in Latvia, together with 29 local drug manufacturers and 84 drug
wholesalers (2016) [22].
There are 84 drug wholesalers; the 5–6 larger companies have a licence to repack
medicines or to label according to good manufacturing practice (GMP) [14]. The
Latvian medicine manufacturers‘ market makes up 4.7% of the total medicine
market [23].






Olainfarm and Grindex are also licensed to produce and export original medicines.
Pharmaceutical sales were €375 million (2016), in 2015 imports of €510 and exports of





1971 (2017) persons work in the Latvian pharmaceutical industry [24].
Approximately 200–300 pharmacists are working in the industry but there are no
statistics in Latvia as registration is not required. 69 persons are members of the
Industrial Pharmacists’ Section (IPS) section of the Pharmacists Society of Latvia (IPS)
Industrial pharmacists are represented by the IPS [13]. IPS has been a member of the
European Industrial Pharmacists’ Group (EIPG) since 2007 [25].
Competences
and roles
Industrial pharmacists work together with health authorities in:
• drug laboratories;
• agencies (registration, expertise, etc.);
• production (qualified person (QP), etc.);
• representative offices;
• drug wholesalers (QP, responsible persons, etc.).
Researchers with a scientific doctoral degree working in drug laboratories are not
included in the register of pharmacists and are not called industrial pharmacists.
A pharmacy degree is not obligatory for employment in R&D laboratories. Some
pharmacy graduates may work in preclinical research, but again they are not
registered and certified pharmacists.
Since 2015 there has been specialisation in Industrial Pharmacy delivered as a joint
programme between RSU and Riga Technical University.
Generally, pharmacists in industry have one of the following posts:
• pre-clinical drug evaluation (safety and efficacy);





• drug evaluation and registration (governmental and industrial).




Pharmacists are employed by the national health authorities and in public sector
agencies (e.g., the the drug pricing agency National Health Service (NHS) of Latvia,
Health Inspectorate of Latvia, State Agency of Medicines of Latvia working on
expertise of medicine dossiers and registration, and in veterinary and agriculture
departments, forensics, etc.).
Others are employed in the private sector in different areas (laboratories,
representative offices for foreign drug firms, medical journalism, etc.).




Education and training, research, management, control, production, consulting, drug
evaluation and registration.
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Industrial pharmacists in Latvia have similar practices and duties to those in other EU countries [1].
As accurate numbers of industrial pharmacists were not available for most European countries,
a comparison with the EU average is not possible. The pharmaceutical market is loss-making in
that imports are greater than exports. In 2015, the pharmaceutical trade balance was negative in the
majority (16/28) of EU countries including Latvia [24]. The Latvian figure of −€178 million is far
less than in some other member states such as Spain (−€2892 million) and Italy (−€2320 million).
Other comparisons can be found in Reference [24]. This situation is relatively stable as figures for
2008 [24] show that 15/27 EU countries have a negative pharmaceutical trade balance with Latvia at
−€160 million, Spain at −€1710 million and Italy at −€1714 million.
Table 6 provides information on professional associations for pharmacists in Latvia.




The Pharmacists’ Society of Latvia (PhSL) is the only professional organisation in
Latvia representing pharmacists and is responsible for the registration of
pharmacists and pharmacists’ assistants [8]. The Latvian government also
authorises the PhSL to perform the certification of pharmacists. This is obligatory





The creation of community pharmacies is under the responsibility of the licensing
section of the State Agency of Medicines [14]; the territorial distribution of






There is an ethical code for pharmacists issued by the PhSL. The society has an
ethical commission; their decision is irrevocable. Sanctions are: instruction,
notification or annulment of the pharmacist certificate. For the pharmacy manager





During the programme accreditation (and re-accreditation) by LATAK (Latvian
National Accreditation Bureau) [26] an expert representative of the PhSL is invited.
The PhSL has an educational section.
They collaborate with both UL and RSU.
3.2. Pharmacy Faculties, Students, and Courses
Table 7 provides details of pharmacy higher-education institutions (HEIs), staff and students
in Latvia.
Comparison to the EU average for ratios such as students/staff is difficult given the Latvian
situation in which both staff and students can be either full-time or part-time and staff may be attached
to the pharmacy department or to another university department.






Universities: University of Latvia (UL)
RSU (RSU)
Colleges for pharmacists’ assistants (see Table 3 and [26]):
Riga Medical College No.1 (RMC)
Red Cross Medical College (RCMC) of RSU (since 2016–2017)
Public pharmacy













In both the main HEIs there is a 5-year degree.
UL: the master‘s degree programme in pharmacy is a continuation of the
pharmacy bachelor programme (model 3 years + 2 years).
RSU: three programmes are related to pharmacy:
1. professional study programme in Pharmacy (5 years). Following the
professional programme, students acquire a pharmacist’s degree equivalent
to a master’s degree allowing them to work in a pharmacy;
2. professional study programme for master’s degree in Health Care (2.5 years)
(sub-division—clinical pharmacy);
3. professional study programme in Industrial Pharmacy (1.5 years) leading to
an Industrial Pharmacist’s professional qualification (RSU and Riga Technical
University joint programme).
Teaching staff
Staff (UL) UL: 12+19RSU: 33
UL: the faculty of medicine teaching staff is composed of 130 persons (elected
part-time or full-time teaching staff) and approximately 70 freelance teachers
(Latvian nationals and guest lecturers from foreign countries), with 12 persons full-
or part-time in pharmacy of which 6 are faculty of medicine professors. Nineteen
other part-time members of the teaching staff in the pharmacy programme (8
professors and associate professors) come from various other faculties (chemistry,
biology, physics, economics, modern languages, etc.).
RSU: The faculty of pharmacy teaching staff is composed of 33 persons (Latvian
nationals) (8 professors, 12 assistant professors, 13 lecturers and assistants). The
teaching staff involved in the pharmacy study programme (70 in all) is composed






UL: pharmacists from community pharmacies, scientific institutions, the Latvian
State Health agency and from the hospital pharmacy. These 4 are lecturers invited
to give academic courses. All certificated pharmacists from community or hospital
pharmacies may act as tutors for pharmacy student trainees in pharmacy practice.
Students have a free choice of the pharmacy for their traineeship. Usually tutors for
trainees are from the main pharmacies in the capital city of Riga. Approximately
50–60 certified pharmacists have been mentors for students during the last 6 years.
RSU: pharmacists from community pharmacies, hospital pharmacies, the
pharmaceutical industry (especially the Industrial Pharmacy programme),
professionals from the Laboratory of Pharmaceutical Pharmacology of the Latvian
Institute of Organic Synthesis.
There are approximately 10 invited lecturers for academic courses in academic year.









UL: 65 full-time places—10 financed by the state budget and 5 financed by UL, 50
financed by private or legal persons. However, the number of matriculated
students is less than the places offered. Gymnasium graduates apply
simultaneously for several programmes at different universities and in the end
choose a programme where state-budget places are available.
RSU: (2016) 48 full-time places—40 financed by the state budget, 8 financed by
private or legal persons, and 20 part-time places (following pharmacists’ assistant






UL: (2017, statistics [28])
• 248 applicants for budget places;
• 105 for self-financed studies.
16.53 applicants/state-budget financed place. For self-financed places there is no
competition.
RSU:
• 161 applicants for full-time;
• 17 for part-time studies.
4.03 applicants/place [29]









UL: requires a General Certificate of Secondary Education with good results in the
centralised national examination in chemistry (A–D level), Latvian and foreign
languages. Assessment in chemistry is the determinant.
RSU: requires a General Certificate of Secondary Education and centralised
national examination in chemistry, Latvian and a foreign language. The main
admission requirement is the assessment in the centralised examination in
chemistry. In case of equal number of points, competition is determined by the
centralised examination assessment in Latvian and in the foreign language.
Part-time students are admitted on the basis of the average grade of their




UL: masters programme graduates and graduates from the RSU pharmacy
programme become registered pharmacists if they work in pharmacies. In other
work places registration is not obligatory. About 90% of graduates start to work in
pharmacies. Later some of them change their working place.







UL: the details of the study programme, study courses, credit points acquired the
first HEI are evaluated.
RSU compares the content and volume of the study courses with appropriate
study courses in the RSU pharmacy programme and decides which courses can be
accepted and which courses need additional examinations.
Fees per year
For home and EU
students
For UL and RSU:
for full-time home students the fee is 2000 € per year, for UL the
state budget place financing is €3386 for bachelor studies and €3558
for master‘s studies;
for RSU state budget place financing for pharmacy studies is €4475;




bachelor programme: €4800/year, master‘s: €5660/year
RSU:
1st and 2nd year—€8000 per year,
3rd, 4th and 5th year—€9000 per year
Table 8 below contains details of specialisation electives.




The UL pharmacy programme (bachelor plus master‘s) and the RSU 5-year
pharmacy programme are aligned with practice in community pharmacies.
Thus the main “specialisation “ is pharmaceutical care. Pharmacists can obtain
other individual skills in other life science branches or during the ERASMUS
exchange programme.
In addition to the above, RSU has 2 specialisations:





RSU teaches courses in subjects such as hospital pharmacy, industrial
technology of drug forms, etc., but these do not lead to a recognised
specialisation diploma.
RSU has opened two programmes for pharmacist specialisation:
• clinical pharmacy master‘s degree programme; and
• (recently) together with Riga Technical University professional Industrial
pharmacy a 1.5-year programme.
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Table 9 provides details of past and present changes in pharmacy education and training in Latvia.






UL: the pharmacy programme was opened in 2000 and therefore it was
constructed according to the Bologna Declaration as two
programmes—bachelor and master‘s degree programmes with an ECTS credit
point system, a diploma supplement, traineeship of 6 months in the 2nd year of
master‘s studies, compulsory and elective subjects, and a student’s research
project.
RSU:
• Introduction of outcomes-based pharmaceutical education.
• Revision of pharmacy study programme, implementation of such study
courses as clinical trials, placement in industrial pharmacy, placement in
hospital pharmacy, four National Degree exams instead of two, one in
pharmaceutical care.
• Transformation of Clinical Pharmacy study programme in 2013 from
academic (2 years) to professional course (2.5 years) by implementing
six-month placement in clinical pharmacy in hospitals.
• New joint study programme in Industrial Pharmacy since 2015.
• 2016: the Academic Information Centre of Latvia started the
implementation of the European Science Foundation project “Support for
Meeting the Requirements Set for EQAR (European Quality Assurance
Register for Higher Education) Agency”. The aim of the project is to
ensure support for meeting the requirements set by EQAR, including
raising the quality of the agency and strengthening its capacity. RSU
participated in the project regarding the accreditation of the management
of studies for Health Care. In 2017 the expert team recommended the
accreditation of the study direction Health Care for all pharmacy






• Introduction of outcomes-based pharmaceutical education
• Improvement of the assessment system. Introduction of e-learning in
full-time studies and part of courses in English.
• RSU: the implementation of the recommendations of the expert team:
“It is recommended to recruit additional younger academic staff with
good command of English. The study infrastructure should be further
improved along with the material technical provisions at laboratories.
The quality assurance system of the pharmacy programme with low
student feedback response rates needs more transparency and revision.
Ensure a consistent and fair approach to the allocation of credit points.”
• Mapping of study programmes, study course outcomes, with
pharmacist’s professional standard.
The main changes envisaged are the further alignement with EU norms and the introduction of
outcomes-based learning of elements in English.
3.3. Teaching and Learning Methods
Table 10 provides details of hours by learning method (for further details on the definitions of the
different methods see Reference [1]).
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Table 10. Student hours by learning method: University of Latvia (UL, top), Riga Stradins University
(RSU, bottom).
UL
Method BachelorProgramme Year 1 Year 2 Year 3
Master‘s
Programme Year 1 Year 2 Total %
Lecture 300 400 250 300 0 1250 24
Tutorial 20 20 0 50 0 90 2
Practical 200 200 250 250 0 900 18
Project (bachelor thesis 400
h and master‘s thesis 800 h) 0 0 400 0 800 1200 24
Traineeship (6 months) 0 0 0 160 800 960 19
Electives 200 100 60 120 0 480 9
Optional 80 80 40 0 0 200 4
Total 800 800 1000 880 1600 5080 100
RSU.
Method Year 1 Year 2 Year 3 Year 4 Year 5 Total %
Lecture 190 130 187 126 0 633 9
Tutorial 47 32 44 46 0 169 2
Practical 540 + 540 561 + 561 598 + 598 724 + 724 160 5006 67.5
Project 0 0 0 0 320 320 4
Traineeship (hospital) 0 0 0 0 54 54 0.7
Traineeship-community 20 0 0 0 648 668 9
Optional/electives 80 160 80 160 80 560 8
Total 1417 1444 1507 1780 1262 7410 100
The pharmacy programme of UL consists of obligatory and elective courses and includes lectures,
seminars, presentation of reports, practicals, and presentation of research projects. Lectures, tutorials
and practicals are given in the first 4 years (3 years bachelor programme and 1 year master’s programme
with additional work on thesis). Electives are of 2 kinds: compulsory electives are pharmacy-oriented;
free-choice electives may be from other programs and other faculties, and can be from the humanities.
Traineeship is carried out in the first and second year of master’s programme years. The main
components of the courses are lectures (24%), practicals (18%) and project work (24%), with traineeship
at 19%. The bachelor thesis provides 15 ECTS and corresponds to 2.5 calendar months; it is an
individual research project and so how many hours one needs to work depends on the chosen topic;
an estimation is given in Table 10. In the same way, the master’s thesis cannot be calculated in hours.
It provides 30 ECTS and corresponds to 5 calendar months or 1 semester. It also is an individual
research project. Traineeship is at the end of the programme before the master’s thesis and can be
carried out at community pharmacies or 3 months in a community pharmacy plus 3 months at a
hospital pharmacy. It is also possible to do 3 months at a pharmacy in another country under the
ERASMUS training programme [6] plus 3 months in a Latvian pharmacy.
At RSU there is a substantial number of practical hours (67.5%) that consist of practical work in
a laboratory in contact with teaching staff and student’s individual work. Lectures and electives are
validated at a session of the faculty committee and then by the University Senate, as is the traineeship
that occurs in the 5th year and occupies 13% of the time.
3.4. Subject Areas
Table 11 provides details of student hours by subject area (for further details on the definitions of
the subject areas see Reference [1]). Student hours are presence hours, not student workload hours. The
generic area includes all issues that do not belong directly to a given appropriate course. For example,
the competence to find and read scientific literature, to use library and internet data basis, to make
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presentations and develop presentation skills, to use computer programs, to write short scientific
literature reviews, to use languages (foreign and Latin), and to use simple laboratory techniques,
common in all laboratories. For the generic area, an estimation is given as these hours do not constitute
a separate course but are embedded in other courses.
Table 11. Student hours by subject area: University of Latvia (UL, top), Riga Stradins University
(RSU, bottom).
UL
Subject Area Bachelor Programme Year 1 Year 2 Year 3 Master‘s Programme Year 1 Year 2 Total %
CHEMSCI 250 250 200 70 0 770 15
PHYSMATH 0 50 0 50 0 100 2
BIOLSCI 100 100 0 100 0 300 6
PHARMTECH 50 100 200 100 0 450 9
MEDISCI 250 300 200 200 0 950 19
LAWSOC 50 0 0 100 0 150 3
GENERIC 100 0 0 100 0 200 4
TRAINEESHIP 0 0 0 160 800 960 19
PROJECT 0 0 400 0 800 1200 24
Total 800 800 1000 880 1600 5080 100
RSU
Subject Area Year 1 Year 2 Year 3 Year 4 Year 5 Total %
CHEMSCI 270 273 160 156 0 859 22
PHYSMATH 72 0 40 0 0 112 3
BIOLSCI 160 60 40 0 0 260 6
PHARMTECH 24 0 392 176 6 598 15
MEDISCI 164 382 184 250 50 1030 26
LAWSOC 32 40 0 144 0 216 6
GENERIC 40 0 0 60 0 100 3
TRAINEESHIP 20 0 0 20 702 742 19
Total 782 755 816 806 758 3917 100
CHEMSOC: chemical sciences; PHYSMATH: physical and mathematical sciences; BIOLSCI: biological sciences;
PHARMTECH: pharmaceutical technology; MEDISCI: medicinal sciences; LAWSOC: law and social sciences;
GENERIC: generic competences.
Taking the MEDISCI/CHEMSCI ratio (950/770 = 1.23 for UL and 1,030/859 = 1.19 for RSU) as
an indicator of the nature of the content of the M. Pharm. degree courses [30], it appears that both
are balanced; elsewhere in the EU the courses of some member states, e.g., Ireland (ratio = 2.6) are
oriented towards medicinal sciences [30]. It should be noted that in a pharmacy department attached
to a medical faculty (UL) and a department that is independent (RSU), ratios are very similar, viz 1.23
and 1.19, respectively.
Full details of the programmes are available on the website of the lists of the accredited study
programmes at Latvian universities [31]. The difference in the total number of hours between this
table and Table 10 is explained by the fact that Table 11 concerns, essentially, contact hours whereas
Table 10 concerns student hours.
At RSU in each study year students have the opportunity to choose elective courses. The hours
spent for each area depends on the student’s choice; for example, a student can increase his/her
PHARMTECH knowledge by choosing “Drug registration” or his/her BIOLSCI knowledge by
choosing “Pharmaco-genetics”.
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3.5. Impact of the Bologna Principles [3]
Table 12 provides details the various ways in which the Bologna declaration impacts on the
pharmacy HEIs of Latvia.






UL: since 2004. Students receive a diploma supplement.
RSU: together with their pharmacy diploma graduates also receive a
diploma supplement in Latvian and English.
“Two main cycles (B
and M) with entry
and exit at B level”
UL: Partial
RSU: No









UL: national credit points (CP) are linked to ECTS and 1 CP corresponds to
1.5 ECTS in Latvian universities. ECTS are also given for all courses and
shown in the course catalogue and in the diploma supplement. ERASMUS
exchange students receive ECTS and UL validates ECTS obtained in
other countries.
RSU: the system is similar to that above. ECTS can also be acquired in a
non-HEI context, e.g., students undergoing a traineeship in another
member state will be assessed in ECTS.
“Addressing
obstacles to mobility”
UL: mobility is organized within the framework of the ERASMUS exchange
or training programme or with different fellowships.
Non-ERASMUS mobility is possible through fellowships such as the
Fulbright fellowship, fellowships from other universities, support from
sponsors, etc.
The university international office and persons in the faculty responsible for
the ERASMUS exchange programmes help with housing and information;
language courses are available. Every year 7–8 pharmacy students receive
ERASMUS fellowships. The number of incoming students in the pharmacy
programme from other countries is irregular. For UL students, the main
mobility problem is finance and the fact that our students work in parallel
to studying. For incoming students, the main problem is the
Latvian language.
RSU has a similar system. Language courses for students are also
organised. Exchange is organised with the Netherlands, Germany, Portugal,
Spain and Poland. Approximately 2–3 pharmacy students have the





UL: the programme is evaluated by international experts and this involves
site visits. The accreditation body is the Higher Education Quality Agency
(AIKA) [32].
AIKA invites international and national experts to site visits and after that
experts write their evaluation report. The final decision lies with the
Council of Higher Education and the Accreditation Commission of the
university. The study programmes were also evaluated by the European
University Association [33].
RSU: a similar system with international experts is used (see Table 9).
European dimension Yes
UL: the faculty of medicine has experience of teaching foreign students in
the General Medicine programme, where 20% of the programme is in
English; some of these students change and are enrolled in the pharmacy
programme. Students attend summer schools when financially possible.
Visiting researchers from Germany, USA and The Netherlands, etc. are
invited to give lectures. Recently, courses (6 ECTS) in the bachelor
programme and 12 ECTS in the master‘s programme have been given
in English.
RSU: our vision is a modern, prestigious university acknowledged in
Europe and the world in the fields of healthcare and social sciences, with
the human being at its centre of attention.
RSU has international students from 53 countries (42% from Germany, 18%
from Sweden.)







UL: 1 staff month. Each year there is an exchange with Germany,
Netherlands, Bulgaria, Italy.





UL: 2 staff months. Each year there is an exchange with Italy, Hungary,
Bulgaria and France.






UL: 8 student months. As degree studies are in Latvian, foreign students
mainly do research and come on ERASMUS fellowships (from Ireland,
Germany, The Netherlands, Sweden).
RSU: 90 incoming students in 2017. In the pharmacy degree all courses are
at the moment in Latvian, which can present a problem. RSU accepts
students to do research projects within the framework of the ERASMUS





UL: Each year students go to Finland, Italy, Portugal, The Netherlands,
Bulgaria, Estonia or Sweden. Courses that do not correspond to the UL
programme are accepted as elective courses or research projects and
validated according to credit points obtained abroad.
RSU: 3 outgoing students in pharmacy in 2017. There is an ERASMUS
exchange in pharmacy with the Netherlands, Germany and Italy.
Regarding the accreditation of courses, when opening a new programme universities have
to receive a license from the government ensuring that the methodologies and procedures of the
external evaluation of the quality of the study programme comply with the standards and guidelines
developed by the European Association for Quality Assurance in Higher Education [24]. Only licensed
programmes can be opened and, after their first year, can apply for accreditation. The accreditation
of programmes is obligatory. The maximal accreditation term is 6 years. After that, re-accreditation
or closure follows. Each year a self-assessment of programmes is written and student feedback is
gathered after each semester and after each course. The internal quality assurance of the faculty and
university system complies with the standards and guidelines for quality assurance in higher education
developed by ENQA [34]. The internal quality assurance system is implemented at the level of faculty
and university and is built on the ENQA guidelines, which determine the procedures for approval
and periodic evaluation of the programme and the degree awarded, student assessment, academic
staff quality, training tools and resources to help students, as well as information systems and public
information. Quality assurance is built on internal and external audits, election of the academic staff,
and competition for administration positions. The implementation, objectives, and learning outcomes
of the programme, as well as the learning process, resources, partnerships, and management systems
are reviewed on a regular basis. All study programmes are constantly accredited and re-accredited.
As the courses are based on EU norms, harmonisation does not appear to be a major problem,
whereas economic and language difficulties are obstacles to exchange.
3.6. Impact of European Union (EU) Directive 2013/55/EC [2]
Table 13 provides details the various ways in which the EC directive impacts on pharmacy
education and training in Latvia.
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Table 13. Ways in which elements of the European Commission (EC) directive (left column) impact on
Latvian pharmacy HEIs.
Item Comments
“Evidence of formal qualifications
as a pharmacist shall attest to
training of at least five years’
duration . . . ”
This applies in Latvia.
UL: globally we find this acceptable. In Latvia only pharmacists with a
master‘s degree are registered as pharmacists. Persons with a bachelor
degree in pharmacy can work in industry, government agencies, in research
institutions, etc. However, 99% of pharmacy bachelors continue their
studies in a master‘s degree programme.
RSU: five years’ education is necessary for pharmacists to develop the
required professionalism. Like other health care specialists, a pharmacist
must work alongside medical specialists. At the same time, a pharmacist
must be able to perform research in chemical and biological areas. Although
a long 5-year duration makes a pharmacist’s education expensive, quality,
professionalism, and the ability to keep up with the latest developments are
the most important attributes.
“ . . . four years of full-time
theoretical and practical training at
a university or at a higher institute
of a level recognised as equivalent,
or under the supervision of a
university;”
This applies in Latvia.
UL: a 4-year programme is acceptable given that with a study year of 10
months‘ duration and 6 months‘ training, plus a 2.5-month bachelor thesis
and 5-month master‘s thesis, this leaves 26.5 months for theoretical and
laboratory training courses.
RSU: pharmacists must have the knowledge, skills and competences in
many areas. It may be possible to provide a theoretical basis in four years,
but not in a shorter time.
“ . . . six-month traineeship in a
pharmacy which is open to the
public or in a hospital, under the
supervision of that hospital’s
pharmaceutical department.”
This applies in Latvia.
Latvia mainly conforms to the different aspects of the EU directive with, notably, a tunnel degree.
4. Discussion and Conclusions
Community pharmacies in Latvia sell Rx (prescription) and OTC (over-the-counter) medicines,
and provide consulting and diagnostic services.
Pharmacists study five years at one of two universities—UL and RSU. At UL, the programme
is based on a bachelor plus master’s 3 + 2 years system; graduates receive a health sciences bachelor
degree in pharmacy followed by a health sciences master’s degree in pharmacy. At RSU, after a
seamless 5-years’ programme, graduates receive a pharmacist’s degree.
The pharmacy curriculum is organized according to the EU directive 2013/55/EU and has the
required courses in medical, biological and pharmaceutical subjects, as well as courses in physics,
languages, and social science. There is a six months’ traineeship in pharmacy at the master’s level,
following the end of theoretical courses. Both the UL and RSU degree courses are thus adapted to
the Bologna principles of student exchange under ERASMUS and other systems. In both courses,
“fundamental” sciences such as CHEMSCI, PHYSMATH and BIOLSCI figure mainly in the first 3 years
(Table 11), whereas more advanced “pharmaceutical” subjects such as MEDISCI are taught throughout
the course i.e., including and up to the end of the 4th year. The 5th year is mainly dedicated to
traineeship (Table 10) as in other EU member states [1]. This chronological coincidence amongst
member states in the teaching of subject areas and in traineeship, within the 5-year course, should
facilitate student exchange. The latter appears to be more impacted by economic and language
problems than by harmonisation.
After three years of practice, university graduates receive a pharmacist’s certificate. Pharmacists
may own and manage community pharmacies or work at community and hospital pharmacies.
The Pharmacy Law of Latvia states that new pharmacies may be opened in the form of a pharmacist’s
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practice, joint practice, or a private company. A pharmacy belonging to a municipality has to be headed
by a certified pharmacist. A closed-type pharmacy may be opened by a hospital or a day-care facility.
After three years of practice, university graduates receive a pharmacist’s certificate. To obtain this
certificate they have to pass an examination and the certificate is valid for 5 years. During this period,
pharmacists have to continue their education and collect 200 academic hours from participation in
professional courses, workshops, seminars, etc. After that, pharmacists may apply to the Certification
Commission for prolongation of their certificate. In practice, new pharmacies are not being opened
and the majority of existing pharmacies now belong to pharmacy chains. Recent amendments to the
Pharmacy Law state that a general pharmacy may be established in the form of a pharmacist’s practice,
a joint practice (a civil law company) or a capital company. If the owner is not a pharmacist, he/she
must to conclude a contract with a certified pharmacist providing pharmaceutical care. If the pharmacy
takes the form of a capital company either a pharmacist must be a shareholder of not less than 50% of
the capital, or certified pharmacists must comprise not less than half of the board members.
Pharmacists’ assistants study for 2.5 years at RMC and RCMC; they are employed at community
or hospital pharmacies but are not allowed to manage a pharmacy.
Individual specialisation is possible during the bachelor and master’s degree theses by choosing
a specific laboratory for a thesis in an appropriate topic, and also by choosing the appropriate elective
courses. Specialisation is not obligatory, and students may choose more practical pharmacy or clinical
courses. RSU offers specialisation programmes in master’s level clinical pharmacy and industrial
pharmacy. Pharmacists are primarily employed in community pharmacies.
Coming back to the observation in the introduction that the health status and context in Latvia
is below the EU average (Table 1), the PHARMINE survey shows that such an observation does
not result from a lack of education or practice, which are similar to EU norms. It may be that the
answer to this dilemma would be a re-orientation and extension of pharmacy services in areas such
as diagnostics, pharmaceutical care, especially concerning chronic illness in the elderly, vaccinations,
public health campaigns, etc. Community and hospital pharmacists actively participate in public
health activities. For example, together with medical students they measure blood pressure and
glucose levels of volunteers in city parks and trains. Pharmacies also organize open days together with
distributors of medical devices, such as demonstrations on how to measure bone density, to control
obesity, to calculate body mass index, and to evaluate hepatic steatosis. While there is still some
way to go until the people of Latvia reach the average health level of European countries, pharmacy
practice and education seem well adapted to help in this process. Finally it should be noted that many
variables contribute to health disparities within and between countries. Pharmacy may play a part
but other influences are much stronger. For example, the cost of health care and access to it are major
determinants of health status.
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